Literature DB >> 12873983

Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H.

Rebecca R Laposa1, Luzviminda Feeney, James E Cleaver.   

Abstract

The lesion-specific DNA polymerase POLH gene is mutated in xeroderma pigmentosum variant (XP-V) patients who exhibit an increased skin cancer incidence from UV exposure. Normal cells in which POLH expression was reduced using short interfering RNAs (siRNAs) were compared with the XP-V cellular phenotype that results from naturally occurring inactivating mutations. Stable clones expressing siRNA had partially reduced POLH protein levels, and intermediate levels of UV sensitivity and S phase checkpoint activation, but similar levels of Mre11 foci as in XP-V cells. Therefore, suppression of POLH expression levels by siRNA recapitulates most of the phenotypes seen in cells from XP-V patients with inactivating mutations in POLH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873983

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation.

Authors:  Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

2.  Pirh2 E3 ubiquitin ligase monoubiquitinates DNA polymerase eta to suppress translesion DNA synthesis.

Authors:  Yong-Sam Jung; Anne Hakem; Razqallah Hakem; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

3.  p53 suppression overwhelms DNA polymerase eta deficiency in determining the cellular UV DNA damage response.

Authors:  Rebecca R Laposa; Luzviminda Feeney; Eileen Crowley; Sebastien de Feraudy; James E Cleaver
Journal:  DNA Repair (Amst)       Date:  2007-09-05

4.  Xeroderma pigmentosum-variant patients from America, Europe, and Asia.

Authors:  Hiroki Inui; Kyu-Seon Oh; Carine Nadem; Takahiro Ueda; Sikandar G Khan; Ahmet Metin; Engin Gozukara; Steffen Emmert; Hanoch Slor; David B Busch; Carl C Baker; John J DiGiovanna; Deborah Tamura; Cornelia S Seitz; Alexei Gratchev; Wen Hao Wu; Kee Yang Chung; Hye Jin Chung; Esther Azizi; Roger Woodgate; Thomas D Schneider; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2008-03-27       Impact factor: 8.551

5.  Human DNA polymerase eta activity and translocation is regulated by phosphorylation.

Authors:  Yih-Wen Chen; James E Cleaver; Zafer Hatahet; Richard E Honkanen; Jang-Yang Chang; Yun Yen; Kai-Ming Chou
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

6.  Caffeine and human DNA metabolism: the magic and the mystery.

Authors:  William K Kaufmann; Timothy P Heffernan; Lea M Beaulieu; Sharon Doherty; Alexandra R Frank; Yingchun Zhou; Miriam F Bryant; Tong Zhou; Douglas D Luche; Nana Nikolaishvili-Feinberg; Dennis A Simpson; Marila Cordeiro-Stone
Journal:  Mutat Res       Date:  2003-11-27       Impact factor: 2.433

7.  Phosphorylated Rad18 directs DNA polymerase η to sites of stalled replication.

Authors:  Tovah A Day; Komariah Palle; Laura R Barkley; Naoko Kakusho; Ying Zou; Satoshi Tateishi; Alain Verreault; Hisao Masai; Cyrus Vaziri
Journal:  J Cell Biol       Date:  2010-11-22       Impact factor: 10.539

Review 8.  Drugging in the absence of p53.

Authors:  Obed Akwasi Aning; Chit Fang Cheok
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.